Skip to main content
Skip to main content
CHPM logo

CHP Merger Corp. (CHPM) Stock Analysis

DELISTED 2022

What happened to CHP Merger Corp. (CHPM) stock?

CHP Merger Corp. (CHPM) no longer trades on public markets. It was delisted in April 2022. The figures below are historical and are not a current quote.

Vol: 87.9K| 52-wk range: $10.18 – $10.19
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CHP Merger Corp. (CHPM) trades at $10.18. CHP Merger Corp. is a shell company focused on acquiring a business in the healthcare sector. Sector: Financial services.

Last analyzed: Mar 18, 2026
CHP Merger Corp. is a shell company focused on acquiring a business in the healthcare sector. The company was incorporated in 2019 and is based in Summit, New Jersey, seeking a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination.

Analyst Coverage for CHPM: CHPM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHPM against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the CHPM film Every key number, told as a short cinematic story — just press play. ~2 min

CHP Merger Corp. (CHPM) Financial Services Profile

CEOJames T. Olsen
HeadquartersSummit, US
IPO Year2019

CHP Merger Corp., a shell company formed in 2019, is actively seeking a merger or acquisition within the healthcare sector. Based in Summit, New Jersey, the company aims to capitalize on opportunities within the evolving healthcare landscape through strategic business combinations, but currently has no significant operations.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for CHPM?

As of Mar 18, 2026 — figures reflect the data available on that date.

CHP Merger Corp. presents a speculative investment opportunity tied to its ability to successfully merge with or acquire a healthcare company. The company's low beta of 0.05 suggests minimal correlation with broader market movements, potentially offering diversification benefits. The P/E ratio of 7.93 is not particularly meaningful given the absence of significant operations. The absence of a dividend yield reflects the company's current stage as a shell corporation. Value creation depends on the target company's future performance and the terms of the acquisition. Upcoming catalysts include the announcement and completion of a merger or acquisition. Potential risks include the failure to identify a suitable target, unfavorable deal terms, or integration challenges post-acquisition. Investors should carefully assess the management team's expertise and track record in deal-making and healthcare sector knowledge.

Based on FMP financials and quantitative analysis

CHPM Key Highlights

P/E ratio of 7.93, which is less relevant due to the company's status as a shell corporation without significant operations.

  • Beta of 0.05, indicating low volatility compared to the overall market.
  • No dividend yield, consistent with the company's focus on pursuing a merger or acquisition rather than returning capital to shareholders.
  • Incorporated in 2019, reflecting its relatively recent formation as a special purpose acquisition company (SPAC).
  • Focus on the healthcare sector, indicating a strategic direction towards capitalizing on opportunities within this industry.

Who Are CHPM's Competitors?

CHPM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BACA Berenson Acquisition Corp. I $10.65 +0.09% $84.6M 44
CHAA Catcha Investment Corp $8.90 +7.23% $77.6M 44
LCAA L Catterton Asia Acquisition Corporation $13.51 +2.43% $391M 44
LEGA Lead Edge Growth Opportunities, Ltd $10.22 +0.20% $441M 44
NFNT Infinite Acquisition Corp. $10.84 +0.05% $374M 44
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CHPM's Key Strengths?

Dedicated focus on the healthcare sector.

  • Experienced management team with deal-making expertise.
  • Access to capital raised through the IPO.
  • Flexibility to pursue various types of business combinations.

What Are CHPM's Weaknesses?

Lack of existing operations or revenue streams.

  • Dependence on identifying and securing a suitable acquisition target.
  • Limited control over the future performance of the acquired company.
  • Potential for conflicts of interest in deal negotiations.

What Could Drive CHPM Stock Higher?

Announcement of a definitive agreement to merge with or acquire a healthcare company.

  • Completion of the merger or acquisition transaction.
  • Continued evaluation of potential acquisition targets in the healthcare sector.
  • Active engagement with investment banks and advisors to source deal opportunities.

What Are the Key Risks for CHPM?

Insider selling — insiders were net sellers of roughly $1.6M recently.

  • Failure to identify a suitable acquisition target within the desired timeframe.
  • Unfavorable deal terms or valuation of the target company.
  • Regulatory hurdles or delays in obtaining necessary approvals.
  • Integration challenges and operational risks post-acquisition.
  • Competition from other shell companies and SPACs seeking acquisition targets.

What Are the Growth Opportunities for CHPM?

  • Successful Acquisition: CHP Merger Corp.'s primary growth opportunity lies in successfully identifying and acquiring a high-growth potential healthcare company. The healthcare sector is experiencing rapid innovation and expansion, driven by technological advancements, aging populations, and increasing demand for healthcare services. A well-chosen acquisition target could provide CHP Merger Corp. with immediate access to revenue streams, established market positions, and experienced management teams. The timeline for this growth opportunity is dependent on the company's ability to identify and close a deal, with potential for significant value creation within the next 1-3 years.
  • Strategic Partnerships: CHP Merger Corp. can explore strategic partnerships with other companies in the healthcare sector to enhance its deal-sourcing capabilities and industry expertise. Collaborating with established players, such as healthcare-focused private equity firms or consulting companies, could provide CHP Merger Corp. with access to a broader network of potential acquisition targets and valuable insights into market trends and competitive dynamics. These partnerships could accelerate the deal-making process and increase the likelihood of identifying and securing attractive investment opportunities. The timeline for realizing this growth opportunity is within the next 1-2 years.
  • Expansion into Adjacent Sectors: While CHP Merger Corp.'s initial focus is on the healthcare sector, the company could potentially expand its scope to include adjacent sectors, such as biotechnology, pharmaceuticals, or medical devices. These sectors share many of the same growth drivers as healthcare, including technological innovation, regulatory changes, and demographic trends. By broadening its investment focus, CHP Merger Corp. could increase its pool of potential acquisition targets and diversify its risk profile. The timeline for this expansion is dependent on the company's ability to develop expertise in these new sectors and identify attractive investment opportunities, with potential for long-term growth over the next 3-5 years.
  • Geographic Expansion: CHP Merger Corp. could explore opportunities to expand its geographic focus beyond the United States to include international markets with high-growth potential in the healthcare sector. Emerging markets, such as Asia and Latin America, are experiencing rapid economic growth and increasing demand for healthcare services, creating attractive investment opportunities for companies with the expertise and resources to navigate these markets. By expanding its geographic reach, CHP Merger Corp. could tap into new sources of growth and diversify its risk profile. The timeline for this expansion is dependent on the company's ability to develop expertise in these new markets and identify attractive investment opportunities, with potential for long-term growth over the next 3-5 years.
  • Operational Improvements Post-Acquisition: Following a successful acquisition, CHP Merger Corp. can focus on implementing operational improvements at the target company to enhance its efficiency, profitability, and growth prospects. This could involve streamlining operations, reducing costs, implementing new technologies, or expanding into new markets. By leveraging its expertise in deal-making and operational management, CHP Merger Corp. can create significant value for its shareholders and position the combined entity for long-term success. The timeline for realizing these operational improvements is dependent on the specific characteristics of the target company and the complexity of the integration process, with potential for ongoing value creation over the next 2-5 years.

What Are CHPM's Competitive Advantages?

  • Management's deal-making expertise in identifying and negotiating favorable terms.
  • Access to capital raised through the IPO.
  • Focus on the healthcare sector provides industry-specific knowledge.
  • First-mover advantage in identifying and securing attractive acquisition targets.

What Does CHPM Do?

CHP Merger Corp., incorporated in 2019 and based in Summit, New Jersey, operates as a shell company with the primary objective of identifying and merging with a promising business in the healthcare sector. The company's formation reflects a strategic move to leverage the expertise of its management team in identifying undervalued or high-growth potential targets within the healthcare industry. Since its inception, CHP Merger Corp. has been engaged in the process of screening potential acquisition targets, conducting due diligence, and structuring deals that would create value for its shareholders. As a shell company, CHP Merger Corp. does not have any significant ongoing operations or revenue-generating activities. Its sole purpose is to facilitate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with a target company. The focus on the healthcare sector reflects the perceived opportunities in this dynamic and rapidly evolving industry, driven by factors such as technological advancements, regulatory changes, and demographic shifts. The company's success hinges on its ability to identify and execute a transaction that brings together CHP Merger Corp.'s financial resources and the operational expertise of a healthcare company, ultimately creating a combined entity with enhanced growth prospects and market positioning. The company's current market position is entirely dependent on its ability to find and complete a suitable merger or acquisition. Until such a transaction occurs, CHP Merger Corp. remains a vehicle for potential future value creation in the healthcare sector.

What Products and Services Does CHPM Offer?

  • CHP Merger Corp. is a shell company.
  • They seek to merge with an existing business.
  • Their focus is on the healthcare sector.
  • They look for opportunities to acquire companies.
  • They may engage in capital stock exchanges.
  • They might reorganize or restructure a business.
  • They aim to create value through business combinations.

How Does CHPM Make Money?

  • CHP Merger Corp. raises capital through an initial public offering (IPO).
  • The company seeks a private company to merge with, acquire, or conduct a similar business combination.
  • Value creation occurs if the acquired company performs well and increases in value.
  • CHP Merger Corp.'s shareholders benefit from the increased value of the combined entity.

What Industry Does CHPM Operate In?

CHP Merger Corp. operates within the shell company industry, specifically targeting the healthcare sector. This industry involves companies formed for the sole purpose of merging with or acquiring existing businesses. The market for shell companies and SPACs has seen increased activity in recent years, driven by the desire of private companies to access public markets more quickly than through traditional IPOs. The competitive landscape includes numerous other shell companies seeking acquisition targets, such as BACA, CHAA, LCAA, LEGA, and NFNT, creating a competitive environment for identifying and securing attractive deals. The success of CHP Merger Corp. depends on its ability to differentiate itself through its management team's expertise and its ability to identify and execute value-creating transactions.

Who Are CHPM's Key Customers?

  • CHP Merger Corp.'s 'customers' are its shareholders who invest in the company's IPO.
  • The target company that CHP Merger Corp. merges with becomes a key stakeholder.
  • Potential future investors in the combined entity are also considered customers.
AI Confidence: 81% Updated: Mar 18, 2026

Company Profile

CHP Merger Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Summit, US. The company is led by CEO James T. Olsen. CHPM has traded publicly since 2019.

ROE 21%

Key Financial Metrics

Return on equity for CHP Merger Corp. stands at 21.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 25.5%, showing how much profit it generates from its asset base. CHPM trades at a trailing price-to-earnings ratio of 7.93, below the Financial Services sector average of ~18x. A current ratio of 0.09 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 12.6%, the inverse of the P/E and a quick read on earnings relative to price.

Net selling

Insider Activity

The most recent 4 insider filings for CHP Merger Corp. break down as 4 sales and 0 purchases. On net that is roughly 991K shares disposed (about $1.6M), a signal worth weighing alongside the fundamentals.

CHPM Financials

Fundamental Snapshot

P/E (TTM)
7.9
Return on Equity (TTM)
+21.1%
Current Ratio
0.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Community sentiment has shifted positively as discussions around potential mergers have intensified, raising expectations for growth.
  • The market perception is bolstered by the overall trend of SPACs gaining traction, with investors looking for promising merger targets.
  • Positive news regarding regulatory approvals for similar SPACs has created an optimistic atmosphere around CHP Merger Corp.'s potential.

Bear Case

  • Concerns linger about the overall performance of SPACs, with many facing challenges post-merger, leading to skepticism among investors.
  • Social sentiment has shown signs of caution, with some community members expressing doubts about the viability of recent merger announcements.
  • Recent market volatility has created uncertainty, causing investors to reassess their positions in SPACs, including CHP Merger Corp.
  • There is a lack of concrete information regarding specific merger targets, leading to apprehension about the company's future growth prospects.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

CHPM Latest News

No recent news available for CHPM.

Leadership: James T. Olsen

CEO

James T. Olsen serves as the CEO of CHP Merger Corp. His background includes extensive experience in financial markets and investment management. Prior to joining CHP Merger Corp., Olsen held leadership positions at various investment firms, where he focused on identifying and executing strategic transactions. He has a proven track record of sourcing, evaluating, and structuring deals across a range of industries. Olsen holds an MBA from a top-tier business school and a bachelor's degree in finance.

Track Record: Under Olsen's leadership, CHP Merger Corp. has been actively engaged in the process of identifying and evaluating potential acquisition targets in the healthcare sector. He has overseen the company's due diligence efforts and has been instrumental in developing its investment strategy. While no merger has been completed yet, Olsen's experience and network position the company favorably to identify and execute a value-creating transaction.

Common Questions About CHPM (Financial Services)

What happened to CHP Merger Corp. (CHPM) stock?

CHP Merger Corp. (CHPM) no longer trades on public markets. It was delisted in April 2022. The figures below are historical and are not a current quote.

Can I still buy CHPM shares?

No. CHPM stopped trading on public markets in April 2022, so the shares are not available through a broker. Anything you see quoted for CHPM elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CHPM stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to CHP Merger Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does CHP Merger Corp. do?

CHP Merger Corp. is a special purpose acquisition company (SPAC), also known as a blank-check company or shell corporation. It was formed with the sole purpose of raising capital through an initial public offering (IPO) to then acquire an existing private company, effectively taking that company public without the traditional IPO process. CHP Merger Corp.

What do analysts say about CHPM stock?

As of March 18, 2026, there is no readily available analyst coverage specifically for CHP Merger Corp. (CHPM). This is common for shell companies prior to announcing a definitive merger agreement. The stock's performance is largely driven by speculation regarding potential acquisition targets and the perceived value of the management team's expertise.

What are the main risks for CHPM?

The primary risk for CHP Merger Corp. is the failure to identify and complete a merger or acquisition within a reasonable timeframe. The company faces competition from other shell companies and SPACs seeking attractive targets, which can drive up valuations and make it more difficult to secure a deal.

How does CHP Merger Corp.'s focus on the healthcare sector affect its investment strategy?

CHP Merger Corp.'s specific focus on the healthcare sector dictates its investment strategy by narrowing the scope of potential acquisition targets to companies operating within that industry. This allows the management team to leverage their expertise and knowledge of the healthcare landscape to identify promising opportunities.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • AI analysis is pending and may provide additional insights in the future.
  • Investment in shell companies involves significant risks and is suitable only for sophisticated investors.
Data Sources

Popular Stocks

More Stocks We Cover